Published in Cancer Weekly, July 24th, 1995
The isolation of antibodies that react selectively with human tumor cells has been a major focus of cancer immunology. This has the potential for important applications by targeting diagnostic and therapeutic agents.
To date, no process has succeeded in combining ease, efficiency, and success. Ziaohong Cai et al. constructed a system that maps fusion-phage libraries expressing single-chain Fv antibodies ("Anti-Melanoma Antibodies from Melanoma Patients Immunized with Genetically Modified Autologous Tumor Cells: Selection of Specific...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.